Insider · CIK 0001625184

Schwartz Aharon

Reports to the SEC for 3 companies · CARMIEL

sec.gov

Transactions

Companies

Filings

CIK

0001625184

Forms 4 and 5

Insider transactions

22 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-03	PLXProtalix BioTherapeutics, Inc. · Restricted Stock UnitsA Award	Director	AAward	+8,500 sh	—	—	8,500
2026-09-03	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+17K sh	—	—	17,000
2025-09-03	PLXProtalix BioTherapeutics, Inc.A Award	Director	AAward	+7,500 sh	—	—	7,500
2025-09-03	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2025-06-10	PLXProtalix BioTherapeutics, Inc.P Purchase	Director	PPurchase	+129K sh	$1.60	+$206K	303,000
2023-09-29	PLXProtalix BioTherapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+61.7K sh	—	—	61,676
2023-01-03	PLXProtalix BioTherapeutics, Inc.P Purchase	Director	PPurchase	+110K sh	$1.42	+$156K	174,000
2022-09-07	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2020-04-07	PLXProtalix BioTherapeutics, Inc.P Purchase	Director	PPurchase	+64K sh	$2.43	+$155K	64,000
2020-03-09	Foamix Pharmaceuticals Ltd.OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−38.2K sh	—	—	0
2020-03-09	Foamix Pharmaceuticals Ltd.OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−49.4K sh	—	—	0
2020-03-09	Foamix Pharmaceuticals Ltd.OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−24.9K sh	—	—	0
2020-03-09	Foamix Pharmaceuticals Ltd.OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−21.4K sh	—	—	0
2020-03-09	Foamix Pharmaceuticals Ltd.OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−24K sh	—	—	0
2020-03-09	Foamix Pharmaceuticals Ltd.D Disposition to Issuer	Director	DDisposition to Issuer	−112K sh	—	—	0
2020-02-27	Foamix Pharmaceuticals Ltd.OptionsA Award	Director	AAward	+38.2K sh	—	—	38,156
2020-01-20	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2019-05-16	Foamix Pharmaceuticals Ltd.OptionsA Award	Director	AAward	+49.4K sh	—	—	49,412
2018-11-28	Foamix Pharmaceuticals Ltd.P Purchase	Director	PPurchase	+12.2K sh	$3.88	+$47.4K	112,200
2018-11-27	Foamix Pharmaceuticals Ltd.P Purchase	Director	PPurchase	+50K sh	$3.92	+$196K	100,000
2018-11-26	Foamix Pharmaceuticals Ltd.P Purchase	Director	PPurchase	+50K sh	$3.89	+$195K	50,000
2018-05-08	Foamix Pharmaceuticals Ltd.OptionsA Award	Director	AAward	+24.9K sh	—	—	24,883

Recent filings

Accepted (ET)
Sep 94
Schwartz Aharon0001178913-26-004471
SEC(opens sec.gov)
Sep 44
Schwartz Aharon0001415889-25-023704
SEC(opens sec.gov)
Aug 124
Schwartz Aharon0001415889-25-021494
SEC(opens sec.gov)
Oct 34
Schwartz Aharon0001415889-23-013900
SEC(opens sec.gov)
Jan 54
Schwartz Aharon0001104659-23-001495
SEC(opens sec.gov)
Sep 94
Schwartz Aharon0001104659-22-098948
SEC(opens sec.gov)
Apr 134
Schwartz Aharon0001104659-20-045926
SEC(opens sec.gov)
Mar 114
Schwartz Aharon0001209191-20-018199
SEC(opens sec.gov)
Mar 34
Schwartz Aharon0001209191-20-015201
SEC(opens sec.gov)
Jan 224
Schwartz Aharon0001104659-20-005970
SEC(opens sec.gov)
May 204
Schwartz Aharon0001209191-19-031532
SEC(opens sec.gov)
Dec 64
Schwartz Aharon0001178913-18-003093
SEC(opens sec.gov)

Companies

Address

C/O PROTALIX BIOTHERAPEUTICS, INC. 2 SNUNIT STREET SCIENCE PARK, POB 455

CARMIEL, 2161401